Trying to predict 'dangerous' bladders in children: the area under the curve concept

H Hashim1, J Ellis-Jones, L Swithinbank

  • 1Bristol Urological Institute, Southmead Hospital, Westbury on Trym, Bristol BS10 5NB, UK. hashim@doctors.org.uk

Insights

This study explored using the area under the detrusor pressure curve (AUC) to identify dangerous bladders in children undergoing urodynamics. No correlation was found, likely due to software limitations, highlighting the need for standardized methods.

Area of Science:

  • Pediatric Urology
  • Urodynamics
  • Lower Urinary Tract Dysfunction

Background:

  • Video urodynamics is standard for diagnosing lower urinary tract dysfunction in children.
  • Current methods for predicting 'dangerous' bladders, like bladder compliance, lack standardization in pediatric populations.
  • Detrusor overactivity waves can occur even with normal bladder compliance.

Purpose of the Study:

  • To investigate if the area under the detrusor pressure curve (AUC) during urodynamics filling is a useful predictor of 'dangerous' bladders in children.
  • To address the lack of standardized methods for predicting dangerous bladders in pediatric urodynamics.

Main Methods:

  • Retrospective analysis of raw urodynamics data from 15 children referred to a tertiary center between 2000-2004.
  • Assessment of the area under the detrusor pressure curve (AUC) using available computer software.

Main Results:

  • No significant correlation was found between the AUC and the prediction of 'dangerous' bladders.
  • Limitations in the computer software's ability to accurately determine AUC were identified as a potential confounding factor.

Conclusions:

  • The study did not establish AUC as a predictor of 'dangerous' bladders in this cohort.
  • Significant limitations in current software for AUC calculation necessitate the development of standardized tools.
  • Multinational, multi-center trials and standardization by the International Continence Society are recommended for future research.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated from...
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...